特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポイントオブケア (POC) 診断:技術と世界市場

Point of Care Diagnostics: Technologies and Global Markets

発行 BCC Research 商品コード 895035
出版日 ページ情報 英文 259 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
ポイントオブケア (POC) 診断:技術と世界市場 Point of Care Diagnostics: Technologies and Global Markets
出版日: 2019年07月19日 ページ情報: 英文 259 Pages
概要

世界のポイントオブケア (POC) 診断・検査市場規模は、2018年の193億米ドルから2023年までに255億米ドルへ拡大すると予測され、この間は5.7%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界のポイントオブケア (POC) 診断・検査市場について調査し、POC検査産業の概説、現在・将来の市場規模推計、米国市場の分析、製品セグメント別による分析、市場影響要因の分析、市場動向・将来の展望、市場における主要企業の事業活動レビュー、およびPOC技術の特許などについてまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 産業概要

  • POC検査とは?
  • 業界用語
  • POC検査市場の概要
  • POC製品セグメント
  • 一般的に実施されているPOC検査
  • マルチプレックスPOCT (xPOCT)
  • 米国におけるCLIAの重要性
  • POC検査におけるFDAの役割
  • 世界の公的医療制度
  • 病気の発症率
  • 人口統計・人口高齢化

第4章 世界のPOC検査市場

  • 市場概要
  • 世界市場の規模
  • 世界市場の収益
  • 世界市場におけるメーカーのプレゼンス
  • 市場構造

第5章 市場セグメント

  • 概要
  • 血液化学・電解質検査
  • 心臓マーカー検査
  • コレステロール検査
  • 薬物・アルコール乱用検査
  • グルコース検査
  • 感染症検査
  • 妊娠・受胎能検査
  • 血液・止血検査
  • 腫瘍マーカー検査
  • 尿化学検査
  • その他のPOCテスト
  • 臨床検査改善法(CLIA)

第6章 血液化学・電解質検査

  • セグメントの概要
  • 血液化学のパラメーター
  • 血液ガス分析に対するCLIAの品質管理要件
  • 市場規模
  • 市場参入企業・市場シェア

第7章 心臓マーカー検査

  • セグメントの概要
  • 市場規模
  • 市場参入企業・市場シェア

第8章 コレステロール検査

第9章 薬物・アルコール乱用検査

第10章 グルコース検査

第11章 感染症検査

第12章 妊娠・受胎能検査

第13章 血液・止血検査

第14章 腫瘍マーカー検査

第15章 尿化学検査

第16章 その他のPOC検査

第17章 特許

第18章 企業プロファイル

BBC Researchについて

図表

List of Tables

  • Summary Table: Global Market for POC Testing, by Test Type, Through 2023
    • Table 1: Selected Key Statistics for POC Testing Sites
    • Table 2: Estimated Number of Hospitals/Inpatient Acute Care Centers and Beds Available, by Selected Country, 2016
    • Table 3: Estimated Nursing Homes Residents in U.S., by Selected U.S. States
    • Table 4: Number of Hospice Facilities, by Type
    • Table 5: Selected CLIA-Waived POC Tests
    • Table 6: Global Market Shares of xPOCT, by Segment, 2018
    • Table 7: Pertinent Parameters of GMP Regulations Affecting In Vitro Diagnostics
    • Table 8: Health Expenditures as Percentage of GDP, by Selected Country, 1980-2015
    • Table 9: Health Expenditures as Percentage of GDP, by Top 20 Spenders, 2017
    • Table 10: Hospital Usage Statistics, 2005 vs. 2015
    • Table 11: World Health Organization Ranking of Top 50 Healthcare Systems, 2010
    • Table 12: Statistics of Selected Diseases in the Global Population, 2017 Estimates
    • Table 13: Birth Rates and Births, by Country, 2017 Estimates
    • Table 14: Estimated Global Population and Annual Growth, by Selected Age Group and Selected Years, Through 2030
    • Table 15: Population Growth, by Selected Country/Region, Through 2015
    • Table 16: Global Life Expectancy at Birth, by Selected Country, 1980 and 2010
    • Table 17: U.S. Population Estimates and Projections, by Age Group, 1900-2050
    • Table 18: Estimates of Expected U.S. Life Expectancy at Birth with Projections, by Sex, 1990-2020
    • Table 19: Global Life Expectancy at Birth, by Selected Country, 1980 and 2015
    • Table 20: Global Market for POC Testing, by Test Type, Through 2023
    • Table 21: North American Market for POC Testing, by Test Type, Through 2023
    • Table 22: European Market for POC Testing, by Test Type, Through 2023
    • Table 23: Asia-Pacific Market for POC Testing, by Test Type, Through 2023
    • Table 24: LAAM Market for POC Testing, by Test Type, Through 2023
    • Table 25: Global Market Share for POC Testing, by Major Participant, 2018
    • Table 26: CLIA-Waived Tests for Hematology Applications, Through May 2019
    • Table 27: CLIA-Waived Tests for Chemistry Applications, Through May 2019
    • Table 28: CLIA-Waived Tests for Drugs of Abuse Applications, Through May 2019
    • Table 29: CLIA-Waived Tests for Endocrine Applications, Through May 2019
    • Table 30: CLIA-Waived Tests for General Immunology Applications, Through May 2019
    • Table 31: CLIA-Waived Tests for Bacteriology Applications, as of May 2019
    • Table 32: CLIA-Waived Tests for Parasitology Applications, as of May 2019
    • Table 33: CLIA-Waived Tests for Virology Applications, as of May 2019
    • Table 34: CLIA-Waived Tests for Urology Applications, as of May 2019
    • Table 35: Global Market Shares of xPOCT vs. Single Analyte for Blood Gas/Electrolyte Testing, 2018
    • Table 36: Global Manufacturer Market Shares of Blood Gas Analyzer POC Tests, 2018
    • Table 37: Abaxis Piccolo Analyzer Test Availability
    • Table 38: Nova Biochemical POC Stat Profile PHOX Series, by Available Tests
    • Table 39: Global Market Shares of xPOCT vs. Single Analyte Cardiac Marker Testing, 2018
    • Table 40: Global Manufacturers' Market Shares of POC Cardiac Marker Tests, 2018
    • Table 41: Global Market Shares of xPOCT vs. Single Analyte Cholesterol Testing, 2018
    • Table 42: Global Manufacturers' Market Shares of Rapid Cholesterol POC Tests, 2018
    • Table 43: Global Market Shares of xPOCT vs. Single Analyte Drug Testing, 2018
    • Table 44: Global Manufacturers' Market Shares of Rapid Drug and Alcohol POC Tests, 2018
    • Table 45: Global Market Shares of xPOCT vs. Single Analyte Glucose Testing, 2018
    • Table 46: Global Manufacturers' Market Shares of Glucose Meters and Supplies, 2018
    • Table 47: Global Market Shares of Infectious Disease POC Tests, by Type, 2018
    • Table 48: Global Market Shares of xPOCT vs. Single Analyte Infectious Disease Testing, 2018
    • Table 49: Global Manufacturers' Market Shares of Rapid Infectious Disease POC Tests, 2018
    • Table 50: Global Market Shares of Pregnancy vs. Fertility POC Tests, by Type, 2018
    • Table 51: Global Market Shares of xPOCT vs. Single Analyte Pregnancy/Fertility Testing, 2018
    • Table 52: Global Manufacturers' Market Shares of Rapid Pregnancy/Fertility POC Tests, 2018
    • Table 53: Global Market Shares of xPOCT vs. Single Analyte Hematology Testing, 2018
    • Table 54: Global Manufacturers' Market Shares of Rapid Hemoglobin/Hemostasis POC Tests, 2018
    • Table 55: Global Market Shares of xPOCT vs. Single Analyte Tumor Marker Testing, 2018
    • Table 56: Global Manufacturers' Market Shares of Rapid Tumor Marker POC Tests, 2018
    • Table 57: Global Market Shares of xPOCT vs. Single Analyte Testing for Urinalysis, 2018
    • Table 58: Global Manufacturers' Market Shares of POC Urine Chemistry Analyzers, 2018
    • Table 59: Global Market Shares of xPOCT vs. Single Analyte Testing for Other Tests, 2018
    • Table 60: Global POC Testing-Related Patents Granted, 2018-2019
    • Table 61: Roche's Diagnostic: Acquisitions, 2014-2016

List of Figures

  • Summary Figure: Global Market for POC Testing, by Test Type, 2018-2023
    • Figure 1: Estimated Number of Inpatient Care Facilities and Available Beds, by Selected Country, 2016
    • Figure 2: Health Expenditures as Percentage of GDP, by Country, 1980-2015
    • Figure 3: Health Expenditures as Percentage of GDP, by Top 20 Spenders, 2017
    • Figure 4: Hospital Usage Statistics, 2005 and 2015
    • Figure 5: Birth Rates and Births, by Country, 2017 Estimates
    • Figure 6: Estimated Global Population, by Selected Age Group and Selected Years, 2000-2030
    • Figure 7: Population Growth, by Selected Country/Region, 2010 and 2015
    • Figure 8: Global Life Expectancy at Birth, by Selected Country, 1980 and 2010
    • Figure 9: U.S. Population Estimates and Projections, by Age Group, 1900-2050
    • Figure 10: Estimates of Expected U.S. Life Expectancy at Birth with Projections, by Sex, 1990-2020
    • Figure 11: Global Life Expectancy at Birth, by Selected Country, 1980 and 2015
    • Figure 12: Global Market for POC Testing, by Test Type, 2018 and 2023
    • Figure 13: Global Market Share for POC Testing, by Test Type, 2018
    • Figure 14: Global Market Share for POC Testing, by Major Participant, 2018
    • Figure 15: Distribution Channels: POC Diagnostic Devices
    • Figure 16: Global Market Shares of xPOCT vs. Single Analyte for Blood Gas/Electrolyte Testing, 2018
    • Figure 17: Global Manufacturer Market Shares of Blood Gas Analyzer POC Tests, 2018
    • Figure 18: Global Market Shares of xPOCT vs. Single Analyte Cardiac Marker Testing, 2018
    • Figure 19: Global Manufacturers' Market Shares of POC Cardiac Marker Tests, 2018
    • Figure 20: Global Market Shares of xPOCT vs. Single Analyte Cholesterol Testing, 2018
    • Figure 21: Global Manufacturers' Market Shares of Rapid Cholesterol POC Tests, 2018
    • Figure 22: Global Market Shares of xPOCT vs. Single Analyte Drug Testing, 2018
    • Figure 23: Global Manufacturers' Market Shares of Rapid Drug and Alcohol POC Tests, 2018
    • Figure 24: Global Market Shares of xPOCT vs. Single Analyte Glucose Testing, 2018
    • Figure 25: Global Manufacturers' Market Shares of Glucose Meters and Supplies, 2018
    • Figure 26: Global Market Shares of Infectious Disease POC Tests, by Type, 2018
    • Figure 27: Global Market Shares of xPOCT vs. Single Analyte Infectious Disease Testing, 2018
    • Figure 28: Global Manufacturers' Market Shares of Rapid Infectious Disease POC Tests, 2018
    • Figure 29: Global Market Shares of Pregnancy vs. Fertility POC Tests, by Type, 2018
    • Figure 30: Global Market Shares of xPOCT vs. Single Analyte Pregnancy/Fertility Testing, 2018
    • Figure 31: Global Manufacturers' Market Shares of Rapid Pregnancy/Fertility POC Tests, 2018
    • Figure 32: Global Market Shares of xPOCT vs. Single Analyte Hematology Testing, 2018
    • Figure 33: Global Manufacturers' Market Shares of Rapid Hemoglobin/Hemostasis POC Tests, 2018
    • Figure 34: Global Market Shares of xPOCT vs. Single Analyte Tumor Marker Testing, 2018
    • Figure 35: Global Manufacturers' Market Shares of Rapid Tumor Marker POC Tests, 2018
    • Figure 36: Global Market Shares of xPOCT vs. Single Analyte Testing for Urinalysis, 2018
    • Figure 37: Global Manufacturers' Market Shares of POC Urine Chemistry Analyzers, 2018
    • Figure 38: Global Market Shares of xPOCT vs. Single Analyte Testing for Other Tests, 2018
目次
Product Code: HLC043F

Report Highlights:

The global market for point of care (POC) diagnostics and testing should grow from $19.3 billion in 2018 to $25.5 billion by 2023 with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2023.

The global market for glucose monitoring tests should grow from $8.1 billion in 2018 to $9.9 billion by 2023 with a CAGR of 4.1% from 2018 to 2023.

The global market for cardiac marker testing should grow from $2.0 billion in 2018 to $3.2 billion by 2023 with a CAGR of 9.9% from 2018 to 2023.

Report Scope:

This study will describe the market for POC diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players. Specifically, the report -

  • Describes the POC testing industry.
  • Estimates the current and future market size.
  • Provides breakdowns for U.S. markets.
  • Describes product segments and the continuous updating of POC products.
  • Analyzes market influences in the industry and predicts the changes that will shape the future POC testing market.
  • Discusses trends within the market and provides a future outlook.
  • Reviews business activities of market leaders.
  • Lists patents for POC technologies.

Report Includes:

  • 43 data tables and 19 additional tables
  • An overview of the global markets for point of care (POC) diagnostics and testing within healthcare industry
  • Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • A look at the diagnostic testing industry featuring current trends, government regulations and growth drivers that will shape the future POC testing market
  • Assessment of competitive landscape and current product suppliers and some of their technologies and market shares within the POC industry
  • Patent study and analysis covering all significant developments in POC technologies
  • Company profiles of major global players within the POC market, including Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Co., Danaher Corp., Roche and Siemens Medical Solutions

Table of Contents

Chapter 1 - Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Contribution of the Study and Intended Audience
  • Scope of Report
  • Defining POC Testing
  • Methodology
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 - Summary and Highlights

  • Overview
  • Major Findings

Chapter 3 - Industry Overview

  • What is POC Testing?
  • Industry Terms
  • Overview of the POC Testing Market
    • POC as Part of the Clinical Diagnostics Industry Structure
    • Medical Benefits Derived from Immediate Diagnostic Testing
    • POC Testing Sites
    • Home Use/Self-Care
    • Emergency Rooms
    • Critical-Care Units
    • Bedside Testing
    • Operating Rooms/Procedure Rooms
    • Physicians' Offices/Clinics/Treatment Centers/Other Noncritical-Care Sites
    • Nursing Homes and Hospice
  • POC Product Segments
    • Blood Chemistry and Electrolytes
    • Cardiac Marker
    • Cholesterol Testing/Monitoring
    • Drug and Alcohol Screening
    • Glucose Testing and Monitoring
    • Infectious Disease Testing
    • Pregnancy and Fertility Testing
    • Hemoglobin and Hemostasis
    • Tumor Marker
    • Urinalysis/Urine Chemistry
  • Commonly Performed POC Tests
  • Multiplex POCT (xPOCT)
  • Significance of CLIA in the United States
  • The FDA's Role in POC Testing
    • Good Manufacturing Practice
  • Forces Driving the POC Testing Market
    • Cost Containment
    • Rising Healthcare Costs
    • Trends in Hospital Length of Stay
  • Public Healthcare Systems Around the World
    • Global Shortage of Healthcare Workers
    • Technological Advancements
    • Availability of Ease of Use Devices
    • New Technologies
  • Incidence of Disease
    • Asthma
    • Cardiovascular Disease
    • Cancer
    • Diabetes
    • Diarrheal Disease
    • HIV
    • Infertility
    • Influenza
    • Malaria
    • Pregnancy
    • Tuberculosis
    • Attention to Drugs of Abuse
  • Demographics and Aging Populations
    • Global Demographics
    • Global Life Expectancy
    • U.S. Demographics
    • Gender, Age and Life Expectancy

Chapter 4 - The Global POC Testing Market

  • Market Overview
  • International Market Size
  • Global Market Revenues
    • North America
    • Europe
    • Asia-Pacific
    • LAAM
  • Presence of Manufacturers in the Worldwide Market
    • Competitor Market Share
  • Market Structure
    • Distribution
    • Promotion
    • Strategic Alliances and Mergers

Chapter 5 - Market Segments

  • Overview
  • Blood Chemistry and Electrolyte Testing
  • Cardiac Marker Testing
  • Cholesterol Testing
  • Drug and Alcohol Abuse Testing
  • Glucose Testing
  • Infectious Disease Testing
  • Pregnancy and Fertility Testing
  • Hematology and Hemostasis Testing
  • Tumor Marker Testing
  • Urine Chemistry Testing
  • Miscellaneous POC Testing
  • Clinical Laboratory Improvement Amendments (CLIA)
    • Hematology
    • Chemistry
    • Alcohol and Drugs of Abuse
    • Endocrine
    • Infectious Disease and Immunology
    • Infectious Disease and Bacteriology
    • Infectious Disease and Parasitology
    • Infectious Disease and Virology
    • Urinalysis

Chapter 6 - Blood Chemistry and Electrolyte Testing

  • Segment Overview
  • Blood Chemistry Parameters
    • Electrolytes
  • CLIA Quality Control Requirements for Blood Gas Analysis
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Abbott Diagnostics
    • Abaxis
    • Alere
    • International Technidyne Corp.
    • Nova Biomedical
    • Radiometer America Inc.
    • Roche Diagnostics
    • Siemens Healthcare

Chapter 7 - Cardiac Marker Testing

  • Segment Overview
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Abbott
    • Alere
    • Roche
    • Response Biomedical
    • Siemens Healthcare

Chapter 8 - Cholesterol Testing

  • Segment Overview
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Abaxis
    • Alere
    • Roche Diagnostics

Chapter 9 - Drug and Alcohol Abuse Testing

  • Segment Overview
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Alere
    • Orasure Technologies
    • Phamatech

Chapter 10 - Glucose Testing

  • Segment Overview
    • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Roche Diagnostics
    • Lifescan
    • Abbott Diabetes Care
    • Trevidia Health
    • Siemens

Chapter 11 - Infectious Disease Testing

  • Segment Overview
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
  • Specific Products for Testing
    • Strep A
    • Influenza
    • Chlamydia
    • Strep A
    • Influenza
    • Chlamydia/Trichomoniasis
    • RSV
    • HIV Testing
    • Infectious Mononucleosis
    • H. pylori
    • Herpes Simplex Virus
    • Syphilis Treponemal

Chapter 12 - Pregnancy and Fertility Testing

  • Segment Overview
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares

Chapter 13 - Hemoglobin/Hemostasis Testing

  • Hematology and Hemostasis
  • Hemostasis (Coagulation)
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares

Chapter 14 - Tumor Marker Testing

  • Segment Overview
  • Fecal and Gastric Occult Blood
  • Bladder Tumor Antigen Test
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Beckman Coulter
    • Quidel
    • Alere

Chapter 15 - Urine Chemistry Testing

  • Segment Overview
  • Market Size
    • xPOCT Market Share
  • Market Participants and Market Shares
    • Roche
    • Siemens

Chapter 16 - Other POC Tests

  • Segment Overview
    • Vaginal pH Tests
    • Thyroid Stimulating Hormone Tests
    • Male Reproductive Tests
    • Menopause
    • Dry Eye
  • Market Size
    • xPOCT Market Share

Chapter 17 - Patents

Chapter 18 - Company Profiles

  • ABAXIS INC.
  • ABBOTT LABORATORIES
  • ALERE INC.
  • BECKMAN COULTER, INC.
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX SA
  • CHEMBIO DIAGNOSTICS, INC.
  • CHURCH & DWIGHT CO., INC.
  • DANAHER CORP.
  • ELITECH GROUP
  • HEMOCUE AB
  • ORTHO CLINICAL DIAGNOSTICS
  • MICRONICS INC.
  • NOVA BIOMEDICAL
  • ORASURE TECHNOLOGIES
  • PHAMATECH INC.
  • QUIDEL CORP.
  • RADIOMETER MEDICAL APS
  • ROCHE
  • SA SCIENTIFIC LTD.
  • SEKISUI DIAGNOSTICS
  • SAVYON DIAGNOSTICS
  • SIEMENS MEDICAL SOLUTIONS
  • TRIVIDIA HEALTH, INC.
  • TRINITY BIOTECH PLC
  • ZOETIS INC.